Amanda Lund Lab

We have had a fantastic first & second day at the #CancerImmuno Conference filled with discussions, networking and cutting edge research. Cancerimmuno 2026! 🇵🇹

The #CancerImmuno conference is packed with four days of opportunities to connect, learn, and share inspiring research. This year's programme features: • 2 panel discussions • 2 group activities • 2 hosted networking dinners • 2 poster sessions

An interesting initiative to use AI to evaluate the validity and rigor of scientific claims and identify gaps in your data and logic. Our collaborative preprint with Carla Nowosad, led by Tenny Mudianto, is highlighted as one of the top 1%! the-one-percent.qedscience.com/?selection=10.…

Last day to vote for new SITC Leadership!

Learn about 2026 SITC At-Large Director candidate, Amanda W. Lund, PhD (NYU Grossman School of Medicine). Read Dr. Lund’s bio and position statement: #lund" target="_blank" rel="nofollow noopener">sitcancer.org/get-involved/2…

Excited to share the preprint of my thesis work, where we've uncovered a continuous lymphatic circuit that recycles tumor-experienced T cells to sustain anti-tumor immunity — with implications for cancer immunotherapy. biorxiv.org/content/10.648… Ty to @theLundLab and coauthors!

New #LundLab preprint from @InesDelclaux ! She shows that the chronicity of the anti-tumor T cell response is fueled in part by continuous T cell migration and functional lymphatic transport. 👇biorxiv.org/content/10.648…

The 2026 SITC Election is now open! SITC members are electing the society’s next Vice President, Secretary/Treasurer and three At-Large Directors. The election closes on Friday, May 15 at 11:59 p.m. EDT. sitcancer.org/get-involved/2…

Dearest gentle reader, we are delighted to announce a new story from our lab published in @Nature describing how a meal's systemic metabolic changes are interpreted by your immune system to enhance adaptive immunity. A thread 1/ nature.com/articles/s4158…

The #SITC election starts on Friday! The three At-Large Directors who receive the plurality of votes will begin three-year terms in 2027. Read the biographies and platform statements of this year’s candidates at #ald" target="_blank" rel="nofollow noopener">sitcancer.org/get-involved/2…

Honored to be nominated for an At-Large Director position on the SITC Board. I'm excited by the opportunity to give back, support their mission, and help to continue pushing the science - and the community - forward #SITC #lund" target="_blank" rel="nofollow noopener">sitcancer.org/get-involved/2…

Announcing your candidates for the 2026 SITC Election! From May 1–15, SITC members will vote to elect the next leaders of the society. Read the biography and platform statement of each candidate here: sitcancer.org/get-involved/2…

📢This is your last chance to register for #CancerImmuno conference!📢 Be quick - only a few spaces remaining! For more information email Felicity (felicity@fusion-conferences.com) or click here to visit the conference website: bit.ly/41SxqWN We look forward to welcoming you to Portugal soon!🌞🇵🇹 #FusionImmunology #FusionCancerResearch

#CancerImmuno Announcement📢 📅Final deadline closing this week (Thursday 16th April 2026, BST!) This is your last opportunity to register and join us at the conference! Register now! we look forward to welcoming you to Portugal soon! 🇵🇹🌞 🔗bit.ly/4t2fSTW

Come join us this summer! Registration deadline is this week! We have an incredible line up of speakers and plans for lots of engaging discussions about the next steps for the field!

🎧 Tune in to the latest episode! Dr. Amanda Lund (@theLundLab) at @nyugrossman joins us to talk about how #lymphatic vessels actively regulate #immune responses rather than simply serving as passive conduits. 🔊 Listen now: bit.ly/3PWia8C

🚨Final Registration Deadline Fast Approaching🚨 Make sure to register before Thursday 16th April 2026 to secure you place at the conference! Click here to register: bit.ly/4rKb0Bj The Fusion team and conference chairs look forward to welcoming you to Lisbon Soon! 🌞🧬🇵🇹 #CancerImmuno #FusionImmunology #FusionCancerResearch

The Emerging Leader Awards are going global and applications are open! Send in your LOI - its an incredible community to be a part of.

In this #EditorsChoice, data from @thelundlab show that CXCR6 promotes the adaptation of T cells as they engage antigen in tissue to increase the probability of survival, memory differentiation, and long-term residence. 🔗 ow.ly/CYUw50Yn5z2

🚨Quick! Head to the #CancerImmuno website now! Time is ticking! Click Here: bit.ly/4aCoYyF🚨